Literature DB >> 15728487

Overlapping signaling pathways of sphingosine 1-phosphate and TGF-beta in the murine Langerhans cell line XS52.

Heinfried H Radeke1, Henrik von Wenckstern, Kirsten Stoidtner, Bettina Sauer, Stefanie Hammer, Burkhard Kleuser.   

Abstract

TGF-beta has been defined as a key mediator for the induction and maintenance of immunological tolerance. Concomitantly, it is essential for homeostasis of specialized epithelial dendritic cells, namely, Langerhans cells (LC). Our data reveal that TGF-beta induces migration of the immature LC, XS52, a cell line expressing the signaling components, TGF-beta type I and II receptors and Smad2, 3, and 4 mRNA. TGF-beta stimulation induced transient Smad3/4 oligomerization and Smad3/DNA binding. Antisense oligonucleotides (ASO) targeting Smad3 abrogated TGF-beta-induced XS52 chemotaxis, proving the involvement of this Smad protein in the TGF-beta-dependent migration. In contrast, the typical CCR6-dependent chemotaxis of immature LC induced by CCL20/MIP-3alpha was not affected by Smad3 ASO. Most notably, we also identified the lysophospholipid sphingosine 1-phosphate (S1P) as a potent chemoattractant for immature LC, which expressed mRNA transcripts of lysophospholipid receptors S1P(1-4). Additional experiments with specific ASO showed that the Galpha(i)-coupled receptors S1P(1) and S1P(3) were dominantly involved in the S1P-induced migration. In contrast, lysophosphatidic acid (LPA), also binding to members of the lysophospholipid receptor family, failed to induce XS52 migration. Intriguingly, we raised evidence that TGF-beta and S1P signal transduction pathways are indeed overlapping, as S1P augmented Smad activation and targeted DNA binding with kinetics comparable to TGF-beta. Finally, S1P failed to stimulate XS52 chemotaxis when Smad3 protein expression was abrogated. Thus, our data indicate a cross-communication between S1P and TGF-beta signaling that might be relevant for more than only migratory activities of immature LC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15728487     DOI: 10.4049/jimmunol.174.5.2778

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection.

Authors:  Casey W Shuptrine; Reham Ajina; Elana J Fertig; Sandra A Jablonski; H Kim Lyerly; Zachary C Hartman; Louis M Weiner
Journal:  Cancer Immunol Immunother       Date:  2017-08-02       Impact factor: 6.968

Review 2.  Dendritic cells at the oral mucosal interface.

Authors:  C W Cutler; R Jotwani
Journal:  J Dent Res       Date:  2006-08       Impact factor: 6.116

3.  Immunomodulator FTY720 induces myofibroblast differentiation via the lysophospholipid receptor S1P3 and Smad3 signaling.

Authors:  Christina D Keller; Pilar Rivera Gil; Markus Tölle; Markus van der Giet; Jerold Chun; Heinfried H Radeke; Monika Schäfer-Korting; Burkhard Kleuser
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis.

Authors:  Keith R Stayrook; Justin K Mack; Donna Cerabona; Daniel F Edwards; Hai H Bui; Maria Niewolna; Pierrick Gj Fournier; Khalid S Mohammad; David L Waning; Theresa A Guise
Journal:  Bonekey Rep       Date:  2015-07-08

5.  The immunomodulator FTY720 and its phosphorylated derivative activate the Smad signalling cascade and upregulate connective tissue growth factor and collagen type IV expression in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Wolfgang Eberhardt; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2006-01       Impact factor: 8.739

Review 6.  Sphingolipids in neutrophil function and inflammatory responses: Mechanisms and implications for intestinal immunity and inflammation in ulcerative colitis.

Authors:  Mel Pilar Espaillat; Richard R Kew; Lina M Obeid
Journal:  Adv Biol Regul       Date:  2016-11-14

7.  FTY720 suppresses interleukin-1beta-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism.

Authors:  C Xin; S Ren; W Eberhardt; J Pfeilschifter; A Huwiler
Journal:  Br J Pharmacol       Date:  2007-02-26       Impact factor: 8.739

8.  Involvement of the lysophosphatidic acid-generating enzyme autotaxin in lymphocyte-endothelial cell interactions.

Authors:  Tae Nakasaki; Toshiyuki Tanaka; Shinichi Okudaira; Michi Hirosawa; Eiji Umemoto; Kazuhiro Otani; Soojung Jin; Zhongbin Bai; Haruko Hayasaka; Yoshinori Fukui; Katsuyuki Aozasa; Naoya Fujita; Takashi Tsuruo; Keiichi Ozono; Junken Aoki; Masayuki Miyasaka
Journal:  Am J Pathol       Date:  2008-09-25       Impact factor: 4.307

Review 9.  Cross-talk at the crossroads of sphingosine-1-phosphate, growth factors, and cytokine signaling.

Authors:  Deborah A Lebman; Sarah Spiegel
Journal:  J Lipid Res       Date:  2008-04-02       Impact factor: 5.922

10.  Sphingosine kinases and sphingosine-1-phosphate are critical for transforming growth factor beta-induced extracellular signal-regulated kinase 1 and 2 activation and promotion of migration and invasion of esophageal cancer cells.

Authors:  Anna V Miller; Sergio E Alvarez; Sarah Spiegel; Deborah A Lebman
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.